HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiat Ruxrungtham Selected Research

Coinfection

1/2021Incident Liver Cirrhosis, Associated Factors, and Cardiovascular Disease Risks Among People Living With HIV: A Longitudinal Study.
9/2020Characteristics of suboptimal immune response after initiating antiretroviral therapy among people living with HIV with a pre-treatment CD4 T cell count <200 ​cells/mm3 in Thailand.
11/2015Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients.
1/2015Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients.
1/2015Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand.
9/2014Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
9/2014Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy.
1/2014Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy.
1/2014CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapy.
5/2013Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiat Ruxrungtham Research Topics

Disease

31Infections
01/2021 - 09/2003
23Coinfection
01/2021 - 10/2003
15HIV Infections (HIV Infection)
07/2020 - 06/2004
13Acquired Immunodeficiency Syndrome (AIDS)
01/2021 - 12/2008
12Tuberculosis (Tuberculoses)
01/2022 - 01/2005
9Body Weight (Weight, Body)
07/2019 - 05/2003
9Hypersensitivity (Allergy)
03/2018 - 06/2006
8Viremia
09/2021 - 06/2004
5Allergic Rhinitis
01/2021 - 09/2003
5Hepatitis B
09/2020 - 03/2002
5Fibrosis (Cirrhosis)
09/2014 - 09/2008
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 09/2008
4Schizophrenia (Dementia Praecox)
06/2018 - 01/2017
4Exanthema (Rash)
03/2018 - 01/2005
4Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2008 - 09/2003
3Disease Progression
01/2018 - 05/2004
3Dengue (Dengue Fever)
03/2017 - 01/2014
3Asthma (Bronchial Asthma)
01/2016 - 06/2002
3Liver Diseases (Liver Disease)
09/2014 - 09/2008
2Virus Diseases (Viral Diseases)
12/2021 - 06/2015
2Diabetes Mellitus
01/2021 - 01/2017
2Hepatitis C
09/2020 - 09/2014
2Obstructive Sleep Apnea
08/2020 - 12/2014
2Human Influenza (Influenza)
01/2020 - 11/2019
2Eosinophilia
03/2018 - 10/2016
2Lipodystrophy
01/2017 - 01/2015
2Opportunistic Infections (Opportunistic Infection)
01/2016 - 01/2015
2Anaphylaxis (Anaphylactic Shock)
03/2015 - 12/2010
2Hepatitis
05/2013 - 05/2004
2Dizziness (Lightheadedness)
07/2011 - 01/2010
1Leptospirosis
01/2022
1COVID-19
07/2021
1Severe Dengue
09/2020
1Rhinitis
08/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2020
1Syphilis
01/2020
1Atherosclerosis
11/2019
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2019
1Erythema Multiforme
03/2018
1Stevens-Johnson Syndrome (Lyell's Syndrome)
03/2018

Drug/Important Bio-Agent (IBA)

14Pharmaceutical PreparationsIBA
03/2018 - 01/2006
11RNA (Ribonucleic Acid)IBA
09/2021 - 05/2004
10Tenofovir (Viread)FDA Link
07/2019 - 01/2008
9NucleosidesIBA
07/2020 - 09/2003
8VaccinesIBA
01/2022 - 10/2010
8DNA (Deoxyribonucleic Acid)IBA
09/2020 - 09/2008
8Reverse Transcriptase InhibitorsIBA
07/2020 - 09/2003
8efavirenz (Sustiva)FDA Link
01/2016 - 01/2005
8Ritonavir (Norvir)FDA Link
01/2016 - 05/2003
8Rifampin (Rifampicin)FDA LinkGeneric
10/2012 - 01/2005
6Stavudine (Zerit)FDA LinkGeneric
01/2021 - 06/2004
6Nevirapine (Viramune)FDA Link
06/2011 - 01/2005
5Protease Inhibitors (Protease Inhibitor)IBA
01/2016 - 03/2007
5AntigensIBA
09/2015 - 03/2005
5Rilpivirine (TMC-278)IBA
01/2014 - 01/2010
5Hepatitis B e AntigensIBA
01/2014 - 09/2008
5Lamivudine (Epivir)FDA Link
03/2012 - 09/2005
4Tryptophan (L-Tryptophan)FDA Link
06/2018 - 01/2017
4DNA VaccinesIBA
03/2017 - 03/2013
4Alanine Transaminase (SGPT)IBA
09/2014 - 01/2005
3N-acetyltalosaminuronic acid (NAT)IBA
09/2020 - 05/2004
3Lipopolysaccharide ReceptorsIBA
09/2020 - 03/2011
3Antiviral Agents (Antivirals)IBA
01/2020 - 04/2007
3Immunoglobulin A (IgA)IBA
01/2018 - 01/2017
3AllergensIBA
09/2014 - 09/2003
3Indinavir (Crixivan)FDA Link
10/2012 - 05/2003
3LipidsIBA
07/2011 - 03/2007
2Biomarkers (Surrogate Marker)IBA
09/2020 - 05/2013
2Hemoglobins (Hemoglobin)IBA
09/2020 - 07/2013
2SteroidsIBA
08/2020 - 12/2014
2Adrenal Cortex Hormones (Corticosteroids)IBA
08/2020 - 01/2016
2Oseltamivir (Tamiflu)FDA Link
01/2020 - 11/2019
2Immunoglobulin M (IgM)IBA
01/2018 - 01/2017
2Neutralizing AntibodiesIBA
09/2015 - 01/2014
2Proteins (Proteins, Gene)FDA Link
09/2015 - 09/2008
2Atazanavir Sulfate (Reyataz)FDA Link
05/2015 - 12/2013
2Vitamin DFDA LinkGeneric
09/2014 - 01/2014
2Interleukin-10 (Interleukin 10)IBA
09/2014 - 05/2013
2etravirine (TMC-125)FDA Link
01/2014 - 01/2011
2Emtricitabine (Emtriva)FDA Link
01/2010 - 01/2008
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2005 - 09/2003
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2022
1SaponinsIBA
01/2022
1Subunit VaccinesIBA
01/2022
1Double-Stranded RNA (RNA, Double Stranded)IBA
12/2021
1HDL LipoproteinsIBA
01/2021
1Interleukin-7 (Interleukin 7)IBA
09/2020
1NucleotidesIBA
07/2020
1Methamphetamine (Desoxyn)FDA LinkGeneric
01/2020
1C-Reactive ProteinIBA
11/2019
1HIV hyperimmune globulinIBA
11/2019
1Intravenous Immunoglobulins (IVIG)FDA Link
11/2019
1CobicistatIBA
07/2019
1elvitegravirIBA
07/2019
1emtricitabine tenofovir alafenamideIBA
07/2019
1Antitubercular AgentsIBA
03/2018

Therapy/Procedure

33Therapeutics
01/2022 - 09/2003
13Highly Active Antiretroviral Therapy (HAART)
01/2017 - 05/2004
12Art Therapy
01/2022 - 01/2005
3Immunotherapy
01/2021 - 09/2014